InvestorsHub Logo
Followers 1
Posts 141
Boards Moderated 0
Alias Born 01/12/2009

Re: None

Tuesday, 06/13/2017 8:52:24 AM

Tuesday, June 13, 2017 8:52:24 AM

Post# of 9287
.........launched LYMPHOSEEK® (technetium TC 99m tilmanocept), originally developed by Navidea, in Denmark, the Netherlands and the UK.

Which is about 16% of the EU population (not to talk about whole Europe). Hope to hear more about a larger sales area soon, e.g. Germany, France, Spain, Italy, etc.
And yes, I'm still optimistic.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NAVB News